Literature DB >> 107327

Vaccinia virus replication. I. Requirement for the host-cell nucleus.

D E Hruby, L A Guarino, J R Kates.   

Abstract

Using cytochalasin B-induced enucleation techniques, we examined the ability of vaccinia virus to replicate in the absence of the host-cell nucleus in several mammalian cell lines. It was found that virus-infected enucleated cells (cytoplasts) prepared from BSC-40, CVC, and L cells were incapable of producing infectious progeny virus. The nature of this apparent nuclear involvement was studied in detail in BSC-40 cells. Modulations designed to maximize cytoplast integrity and longevity, such as reduction of the growth temperature and initial multiplicity of infection, did not improve virus growth in cytoplasts. Sodium dodecyl sulfate-polyacrylamide gel analysis of the [(35)S]methionine pulse-labeled proteins synthesized in vaccinia virus-infected cytoplasts demonstrated that both early and late viral gene products were being expressed at high levels and with the proper temporal sequence. Vaccinia virus cytoplasmic DNA synthesis, as measured by [(3)H]thymidine incorporation, peaked at 3 h postinfection and was 70 to 90% of control levels in cytoplasts. However, in the cytoplasts this DNA was not converted to a DNase-resistant form late in infection, which was consistent with the failure to isolate physical particles from infected cytoplasts. Treatment of vaccinia virus-infected cells with 100 mug of rifampin/ml from 0 to 8 h to increase the pools of viral precursors, followed by subsequent removal of the drug, resulted in a threefold increase virus yield. This treatment had no effect on virus-infected cytoplasts. Finally, vaccinia virus morphogenesis was studied under an electron microscope in thin sections of virus-infected cells and cytoplasts which had been prepared at various times during a single-step growth cycle. It was apparent that, although early virus morphogenetic forms appeared, there was no subsequent DNA condensation or particle maturation in the cytoplasts. These results suggest that vaccinia virus requires some factor or function from the host-cell nucleus in order to mature properly and produce infectious progeny virus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 107327      PMCID: PMC353202     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

Review 1.  Virus assembly.

Authors:  S Casjens; J King
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  MESSENGER RNA IN CELLS INFECTED WITH VACCINIA VIRUS.

Authors:  Y BECKER; W K JOKLIK
Journal:  Proc Natl Acad Sci U S A       Date:  1964-04       Impact factor: 11.205

3.  THE REPLICATION AND COATING OF VACCINIA DNA.

Authors:  W K JOKLIK; Y BECKER
Journal:  J Mol Biol       Date:  1964-12       Impact factor: 5.469

4.  Effect of mitomycin C on the growth of some animal viruses.

Authors:  E REICH; R M FRANKLIN
Journal:  Proc Natl Acad Sci U S A       Date:  1961-08       Impact factor: 11.205

5.  Virus development in enucleate cells: echovirus, poliovirus, pseudorabies virus, reovirus, respiratory syncytial virus and Semliki Forest virus.

Authors:  E A Follett; C R Pringle; T H Pennington
Journal:  J Gen Virol       Date:  1975-02       Impact factor: 3.891

6.  Virus-specific RNA and DNA in nuclei of cells infected with fowlpox virus.

Authors:  L G Gafford; C C Randall
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

7.  Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin).

Authors:  E Katz; E Margalith; B Winer
Journal:  J Gen Virol       Date:  1976-08       Impact factor: 3.891

8.  Vaccinia virus infection of HeLa cells. I. Synthesis of vaccinia DNA in host cell nuclei.

Authors:  P LaColla; A Weissbach
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

9.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

10.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  77 in total

1.  Molecular dissection of the vaccinia virus I7L core protein proteinase.

Authors:  Chelsea M Byrd; Tove' C Bolken; Dennis E Hruby
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

2.  Protection of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3).

Authors:  B A Brody; E Hunter; J D Kluge; R Lasarow; M Gardner; P A Marx
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Biogenesis of poxviruses: role for the DNA-dependent RNA polymerase II of the host during expression of late functions.

Authors:  M Silver; G McFadden; S Wilton; S Dales
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  A host cell membrane protein, golgin-97, is essential for poxvirus morphogenesis.

Authors:  Dina Alzhanova; Dennis E Hruby
Journal:  Virology       Date:  2007-02-05       Impact factor: 3.616

5.  A trans-Golgi network resident protein, golgin-97, accumulates in viral factories and incorporates into virions during poxvirus infection.

Authors:  Dina Alzhanova; Dennis E Hruby
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

6.  Vaccinia virus induces ribonucleotide reductase in primate cells.

Authors:  M B Slabaugh; T L Johnson; C K Mathews
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.

Authors:  A P Rice; W K Roberts; I M Kerr
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  The vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivo.

Authors:  Marika Hedengren-Olcott; Chelsea M Byrd; Jeffrey Watson; Dennis E Hruby
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Cellular expression of a functional nodavirus RNA replicon from vaccinia virus vectors.

Authors:  L A Ball
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  trans processing of vaccinia virus core proteins.

Authors:  P Lee; D E Hruby
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.